Disease/Infection News

RSS

Patients with congenital heart defects have lower risk of severe COVID-19 symptoms

Adults and children born with heart defects had a lower-than-expected risk of developing moderate or severe COVID-19 symptoms, finds a study of more than 7,000 patients from the congenital heart disease center at Columbia University Vagelos College of Physicians and Surgeons.

19 Oct 2020

Researchers study link between psychological responses and risk communication during COVID-19

The mental effects of pandemics on people can arise not only from the burden of preventive measures, the fear of contracting and cure but also coping with the exponential deaths.

19 Oct 2020

Scientists lay out a novel rationale for COVID-19 drug design

American and Polish scientists, reporting Oct. 16 in the journal Science Advances, laid out a novel rationale for COVID-19 drug design - blocking a molecular "scissor" that the virus uses for virus production and to disable human proteins crucial to the immune response.

19 Oct 2020

Dolutegravir is a first-line treatment for people newly diagnosed with HIV

A new study by UBC researchers is set to change international treatment recommendations for people who are newly diagnosed with HIV--an update that could affect nearly two million people per year worldwide.

19 Oct 2020

Engineers visualize how speaking spreads a virus

A team of researchers and engineers at Princeton University has provided a visualization of how speaking produces and expels saliva droplets into the air. The smallest droplets can be inhaled by people, which is the primary mode of transmission of infections such as COVID-19.

19 Oct 2020

Study of patterns of social contacts early on in COVID-19 pandemic

The coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has compelled people worldwide to quarantine. To mitigate the transmission of SARS-CoV-2, countries and workplaces have been under varying stages of lockdown since the detection of the infection in December 2019 in Wuhan, China.

19 Oct 2020

Concerti algorithm identifies intra-patient heteroplasmies in SARS-CoV-2 patients

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus that emerged in Wuhan, China, in late 2019 has caused the ongoing coronavirus disease 2019 (COVID-19) pandemic, which has affected more than 39.8 million lives globally and claimed over 1.11 million deaths to date.

18 Oct 2020

Sinopharm's candidate SARS-CoV-2 vaccine BBIBP-CorV shows promise in clinical trials

Researchers in China have conducted a phase 1/2 trial demonstrating the safety, tolerability, and immunogenicity of a candidate vaccine for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent responsible for the current coronavirus disease 2019 (COVID-19) pandemic.

18 Oct 2020

Future waves of COVID-19 will likely lead to further school closures

Researchers in the UK have warned that given how future waves of coronavirus disease 2019 (COVID-19) seem to be inevitable, it is likely that schools will be put under further pressure to close.

18 Oct 2020

Comparative analysis reveals common vulnerabilities across coronaviruses

Three lethal human respiratory syndromes associated with coronavirus (CoV) infections have emerged in the past two decades. They are severe acute respiratory syndrome (SARS) in 2002, Middle East respiratory syndrome (MERS) in 2012, and coronavirus disease 2019 (COVID-19) in 2019.

18 Oct 2020

WHO study finds Remdesivir and other repurposed drugs ineffective in COVID-19

A large-scale randomized trial has recently been conducted by the World Health Organization (WHO) to evaluate the efficacy of four repurposed antiviral medicines, including Remdesivir, Hydroxychloroquine, Lopinavir, and Interferon, currently used to treat hospitalized coronavirus disease 2019 (COVID-19) patients.

18 Oct 2020

Return to college classes tied to a 9 percent increase in COVID-19 cases, study finds

Since a vast majority of colleges and universities in the country are bringing students back for in-person instruction amid the COVID-19 pandemic, the researchers from the University of Georgia wanted to determine the effect of this return to campus on the viral case growth in countries with a significant college student population, compared to non-college countries.

18 Oct 2020

Obesity changes ACE2 and TMPRSS2 expression in mice: Implications for COVID-19

Researchers studying young obese mice found that expression of ACE2, a receptor in host cells that binds to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is higher in the lungs and trachea of obese mice. The finding could partly explain why obesity is a high-risk factor for COVID-19.

18 Oct 2020

Study examines how international travel restrictions have affected COVID-19 mortality

Travel restrictions implemented early on in the pandemic have been crucial in slowing the spread of the coronavirus and keeping death rates low.

16 Oct 2020

Pooled testing for Covid-19 could significantly increase testing capacity

In a series of recommendations to fix the struggling Covid-19 test, trace and isolate system in England, health researchers from University College London and the London School of Hygiene & Tropical Medicine say that pooled testing for Covid-19 could significantly increase testing capacity in a relatively short space of time and help with the identification of asymptomatic cases in key workers.

16 Oct 2020

Disease/Infection News

Patients with congenital heart defects have lower risk of severe COVID-19 symptoms

Researchers study link between psychological responses and risk communication during COVID-19

Scientists lay out a novel rationale for COVID-19 drug design

Dolutegravir is a first-line treatment for people newly diagnosed with HIV

Engineers visualize how speaking spreads a virus

Study of patterns of social contacts early on in COVID-19 pandemic

Concerti algorithm identifies intra-patient heteroplasmies in SARS-CoV-2 patients

Sinopharm's candidate SARS-CoV-2 vaccine BBIBP-CorV shows promise in clinical trials

Future waves of COVID-19 will likely lead to further school closures

Comparative analysis reveals common vulnerabilities across coronaviruses

WHO study finds Remdesivir and other repurposed drugs ineffective in COVID-19

Return to college classes tied to a 9 percent increase in COVID-19 cases, study finds

Obesity changes ACE2 and TMPRSS2 expression in mice: Implications for COVID-19

Study examines how international travel restrictions have affected COVID-19 mortality

Pooled testing for Covid-19 could significantly increase testing capacity

Key lessons from San Diego's Hepatitis A outbreak can be applied to COVID-19 pandemic

Objective measures reveal a higher prevalence of smell loss in COVID-19 patients

NIH launches adaptive Phase 3 clinical trial to test immune modulator drugs in COVID-19 patients

Healthcare workers experience mental health problems during and after pandemics

Antibody levels drop rapidly in recovering COVID-19 patients, shows study

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Latest News